Abstract
Objective
Gestational diabetes mellitus (GDM) is a prevalent complication during pregnancy associated with numerous adverse outcomes. There is emerging evidence suggesting the potential of probiotics as a therapeutic measure for GDM; however, existing studies have yielded contradictory results. This meta-analysis assessed the efficacy of probiotics on blood glucose management and pregnancy outcomes in patients with GDM.
Methods
A comprehensive search of the PubMed, Embase, and Cochrane databases was conducted up to August 22, 2023, to identify relevant studies. The primary outcomes focused on fasting blood glucose (FBG), fasting serum insulin (FSI), homeostasis model assessment of insulin resistance (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI). The secondary outcomes included various maternal and neonatal outcomes.
Results
This meta-analysis included 15 randomized controlled trials (RCTs), encompassing 1006 patients with GDM. The results showed that, compared to a placebo, probiotics demonstrated a significant reduction in FBG (MD − 2.58, 95% CI − 4.38 to − 0.79, p < 0.01), FSI (MD − 2.29, 95% CI − 3.40 to − 1.18, p < 0.01), HOMA-IR (MD − 0.56, 95% CI − 0.81 to − 0.32, p < 0.01), and birth weight (MD − 101.20, 95% CI − 184.62 to − 17.77, p = 0.02). Furthermore, it resulted in fewer neonatal intensive care unit (NICU) admissions (RR 0.60, 95% CI 0.40–0.89, p = 0.01), instances of hyperbilirubinemia (RR 0.31, 95% CI 0.16–0.61, p < 0.01), and elevated QUICKI (MD 0.01, 95% CI 0.00–0.01, p < 0.01). No significant impact was observed in the other analyzed outcomes.
Conclusions
In conclusion, probiotics improve FBG, FSI, and HOMA-IR, and reduce the occurrence of neonatal hyperbilirubinemia, NICU admissions, and birth weight in the offspring of patients with GDM. However, the quality of the evidence, as per the GRADE approach, varies from high to low, necessitating further studies to consolidate these findings.
Similar content being viewed by others
Data availability
The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO): registration ID CRD42023456637.
References
Szmuilowicz ED, Josefson JL, Metzger BE (2019) Gestational diabetes mellitus. Endocrinol Metab Clin N Am 48(3):479–493. https://doi.org/10.1016/j.ecl.2019.05.001
Lowe WL Jr, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O et al (2018) Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320(10):1005–1016. https://doi.org/10.1001/jama.2018.11628
Alfadhli EM (2015) Gestational diabetes mellitus. Saudi Med J 36(4):399–406. https://doi.org/10.15537/smj.2015.4.10307
Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA (2017) Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 11(11):Cd012037. https://doi.org/10.1002/14651858.CD012037.pub2
Suez J, Zmora N, Segal E, Elinav E (2019) The pros, cons, and many unknowns of probiotics. Nat Med 25(5):716–729. https://doi.org/10.1038/s41591-019-0439-x
Wan J, Ma J (2022) Efficacy of dietary supplements targeting gut microbiota in the prevention and treatment of gestational diabetes mellitus. Front Microbiol 13:927883. https://doi.org/10.3389/fmicb.2022.927883
Babadi M, Khorshidi A, Aghadavood E, Samimi M, Kavossian E, Bahmani F et al (2019) The effects of probiotic supplementation on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Probiotics Antimicrob Proteins 11(4):1227–1235. https://doi.org/10.1007/s12602-018-9490-z
Karamali M, Nasiri N, Taghavi Shavazi N, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M et al (2018) The effects of synbiotic supplementation on pregnancy outcomes in gestational diabetes. Probiotics Antimicrob Proteins 10(3):496–503. https://doi.org/10.1007/s12602-017-9313-7
Kijmanawat A, Panburana P, Reutrakul S, Tangshewinsirikul C (2019) Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: a double-blind randomized controlled trial. J Diabetes Investig 10(1):163–170. https://doi.org/10.1111/jdi.12863
Jamilian M, Amirani E, Asemi Z (2019) The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Clin Nutr (Edinburgh, Scotland) 38(5):2098–2105. https://doi.org/10.1016/j.clnu.2018.10.028
Łagowska K, Malinowska AM, Zawieja B, Zawieja E (2020) Improvement of glucose metabolism in pregnant women through probiotic supplementation depends on gestational diabetes status: meta-analysis. Sci Rep 10(1):17796. https://doi.org/10.1038/s41598-020-74773-8
Ramanathan K, Sirala Jagadeesh N, Vishwanath U, Dayal C, Chandra Babu R, Hayter M (2021) Efficacy of supplementation of probiotics on maternal glycaemic control—a systematic review and meta-analysis of randomized controlled trials. Clin Epidemiol Glob Health 10(2021):100674. https://doi.org/10.1016/j.cegh.2020.11.007
Mahdizade Ari M, Teymouri S, Fazlalian T, Asadollahi P, Afifirad R, Sabaghan M et al (2022) The effect of probiotics on gestational diabetes and its complications in pregnant mother and newborn: a systematic review and meta-analysis during 2010–2020. J Clin Lab Anal 36(4):e24326. https://doi.org/10.1002/jcla.24326
Yefet E, Bar L, Izhaki I, Iskander R, Massalha M, Younis JS et al (2023) Effects of probiotics on glycemic control and metabolic parameters in gestational diabetes mellitus: systematic review and meta-analysis. Nutrients. https://doi.org/10.3390/nu15071633
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928
DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45(Pt A):139–145. https://doi.org/10.1016/j.cct.2015.09.002
Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B et al (2020) GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 119:126–135. https://doi.org/10.1016/j.jclinepi.2019.10.014
Dolatkhah N, Hajifaraji M, Abbasalizadeh F, Aghamohammadzadeh N, Mehrabi Y, Abbasi MM (2015) Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial. J Health Popul Nutr 33:25. https://doi.org/10.1186/s41043-015-0034-9
Lindsay KL, Brennan L, Kennelly MA, Maguire OC, Smith T, Curran S et al (2015) Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial. Am J Obstet Gynecol 212(4):496.e491–411. https://doi.org/10.1016/j.ajog.2015.02.008
Ahmadi S, Jamilian M, Tajabadi-Ebrahimi M, Jafari P, Asemi Z (2016) The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. Br J Nutr 116(8):1394–1401. https://doi.org/10.1017/S0007114516003457
Jafarnejad S, Saremi S, Jafarnejad F, Arab A (2016) Effects of a multispecies probiotic mixture on glycemic control and inflammatory status in women with gestational diabetes: a randomized controlled clinical trial. J Nutr Metab 2016:5190846. https://doi.org/10.1155/2016/5190846
Karamali M, Dadkhah F, Sadrkhanlou M, Jamilian M, Ahmadi S, Tajabadi-Ebrahimi M et al (2016) Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 42(4):234–241. https://doi.org/10.1016/j.diabet.2016.04.009
Badehnoosh B, Karamali M, Zarrati M, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M et al (2018) The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med 31(9):1128–1136. https://doi.org/10.1080/14767058.2017.1310193
Hajifaraji M, Jahanjou F, Abbasalizadeh F, Aghamohammadzadeh N, Abbasi MM, Dolatkhah N (2018) Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial. Asia Pac J Clin Nutr 27(3):581–591. https://doi.org/10.6133/apjcn.082017.03
Nabhani Z, Hezaveh SJG, Razmpoosh E, Asghari-Jafarabadi M, Gargari BP (2018) The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: a randomized double blind placebo controlled clinical trial. Diabetes Res Clin Pract 138:149–157. https://doi.org/10.1016/j.diabres.2018.02.008
Sahhaf Ebrahimi F, Homayouni Rad A, Mosen M, Abbasalizadeh F, Tabrizi A, Khalili L (2019) Effect of L. acidophilus and B. lactis on blood glucose in women with gestational diabetes mellitus: a randomized placebo-controlled trial. Diabetol Metab Syndr. https://doi.org/10.1186/s13098-019-0471-5
Amirani E, Asemi Z, Taghizadeh M (2022) The effects of selenium plus probiotics supplementation on glycemic status and serum lipoproteins in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN 48:56–62. https://doi.org/10.1016/j.clnesp.2022.02.010
Yefet E, Perlitz Y, Yaakov LS, Magril G, Vitner D, Zipori Y et al (2022) The effect of probiotics on glycemic control of women with gestational diabetes mellitus-multicenter, randomized, double blind, placebo controlled-trial. Am J Obstet Gynecol 226(1):S258–S259. https://doi.org/10.1016/j.ajog.2021.11.098
Halkjær SI, de Knegt VE, Lo B, Nilas L, Cortes D, Pedersen AE et al (2020) Multistrain probiotic increases the gut microbiota diversity in obese pregnant women: results from a randomized, double-blind placebo-controlled study. Curr Dev Nutr 4(7):095. https://doi.org/10.1093/cdn/nzaa095
Markowiak-Kopeć P, Śliżewska K (2020) The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. https://doi.org/10.3390/nu12041107
Li Y, Li X, Nie C, Wu Y, Luo R, Chen C et al (2023) Effects of two strains of Lactobacillus isolated from the feces of calves after fecal microbiota transplantation on growth performance, immune capacity, and intestinal barrier function of weaned calves. Front Microbiol 14:1249628. https://doi.org/10.3389/fmicb.2023.1249628
Zhou Y, Duan L, Zeng Y, Song X, Pan K, Niu L et al (2023) The panda-derived Lactiplantibacillus plantarum BSG201683 improves LPS-induced intestinal inflammation and epithelial barrier disruption in vitro. BMC Microbiol 23(1):249. https://doi.org/10.1186/s12866-023-02928-4
Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A et al (2018) Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome 6(1):121. https://doi.org/10.1186/s40168-018-0494-4
Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G (2019) Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab 74(2):115–124. https://doi.org/10.1159/000496426
Roy S, Dhaneshwar S (2023) Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives. World J Gastroenterol 29(14):2078–2100. https://doi.org/10.3748/wjg.v29.i14.2078
Jakubczyk D, Leszczyńska K, Górska S (2020) The effectiveness of probiotics in the treatment of inflammatory Bowel disease (IBD)—a critical review. Nutrients. https://doi.org/10.3390/nu12071973
Wang Y, Wu Y, Wang Y, Xu H, Mei X, Yu D et al (2017) Antioxidant properties of probiotic bacteria. Nutrients. https://doi.org/10.3390/nu9050521
Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A (2021) The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: a parallel double-blind, randomized, placebo-controlled clinical trial. Biomed Pharmacother 141:111915. https://doi.org/10.1016/j.biopha.2021.111915
Callaway LK, McIntyre HD, Barrett HL, Foxcroft K, Tremellen A, Lingwood BE et al (2019) Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial. Diabetes Care 42(3):364–371. https://doi.org/10.2337/dc18-2248
Hasain Z, Che Roos NA, Rahmat F, Mustapa M, Raja Ali RA, Mokhtar NM (2021) Diet and pre-intervention washout modifies the effects of probiotics on gestational diabetes mellitus: a comprehensive systematic review and meta-analysis of randomized controlled trials. Nutrients. https://doi.org/10.3390/nu13093045
Pellonperä O, Mokkala K, Houttu N, Vahlberg T, Koivuniemi E, Tertti K et al (2019) Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled, double-blind clinical trial. Diabetes Care 42(6):1009–1017. https://doi.org/10.2337/dc18-2591
Zhou L, Ding C, Wu J, Chen X, Ng DM, Wang H et al (2021) Probiotics and synbiotics show clinical efficacy in treating gestational diabetes mellitus: a meta-analysis. Prim Care Diabetes 15(6):937–947. https://doi.org/10.1016/j.pcd.2021.08.005
Chu X, Yan P, Zhang N, Feng L, Li X, Wang Y et al (2022) Probiotics for preventing gestational diabetes mellitus in overweight or obese pregnant women: a systematic review and meta-analysis. Clin Nutr ESPEN 50:84–92. https://doi.org/10.1016/j.clnesp.2022.05.007
Acknowledgements
We would like to thank the library of Shenyang Pharmaceutical University for their help in retrieving literature.
Funding
This research received no external funding.
Author information
Authors and Affiliations
Contributions
RW, JSL, JJH, and ZJL all significantly contributed to the study's content and structure. RW and JJH reviewed each experiment for eligibility and extracted and tabulated the relevant data. RW and JSL analyzed the data. RW drafted the article. JJH checked the format of the article. RW, JSL, JJH, and ZJL commented on the article's content. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
This article is based on previously conducted studies and contains no studies with human participants or animals performed by authors.
Institutional review board statement
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, R., Luan, J., Hu, J. et al. Effect of probiotics on pregnancy outcomes in gestational diabetes: systematic review and meta-analysis. Arch Gynecol Obstet (2024). https://doi.org/10.1007/s00404-023-07346-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00404-023-07346-5